Cinacalcet: A Pharmacoeconomic Review of its Use in Secondary Hyperparathyroidism in End-Stage Renal Disease

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.29, Iss.9, 2011-09, pp. : 807-821

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lanthanum Carbonate: A Review of its Use in Lowering Serum Phosphate in Patients with End-Stage Renal Disease

By Curran Monique P. Robinson Dean M.

Drugs, Vol. 69, Iss. 16, 2009-11 ,pp. : 2329-2349

Adis International

Access to resources Recommend Favorite

Sevelamer Hydrochloride: A Review of its Use for Hyperphosphataemia in Patients with End-Stage Renal Disease on Haemodialysis

By Goldsmith David R. Scott Lesley J. Cvetković Risto S. Plosker Greg L.

Drugs, Vol. 68, Iss. 1, 2008-01 ,pp. : 85-104

Adis International

Access to resources Recommend Favorite

Epidemiology of end-stage renal disease

By Roderick Paul

Clinical Medicine, Vol. 2, Iss. 3, 2002-05 ,pp. : 200-204

Royal College Of Physicians

Access to resources Recommend Favorite

Paricalcitol: A Review of its Use in the Management of Secondary Hyperparathyroidism

By Dean M. Robinson Lesley J. Scott

Drugs, Vol. 65, Iss. 4, 2005-01 ,pp. : 559-576

Adis International

Access to resources Recommend Favorite

Galantamine: A Pharmacoeconomic Review of its Use in Alzheimer's Disease

By Lyseng-Williamson K.A. Plosker G.L.

PharmacoEconomics, Vol. 20, Iss. 13, 2002-01 ,pp. : 919-942

Adis International

Access to resources Recommend Favorite